Method for Diagnosing Scleroderma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150185226A1
SERIAL NO

14416334

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an in vitro method for diagnosing scleroderma in a subject, said method comprising the step of detecting in a biological sample obtained from the subject one or more autoantibodies recognizing one or more protein biomarkers selected from the group of proteins consisting of THEX1, AIF1, FGF2, EphB2, CLK1 and ANKS6.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE D'AIX-MARSEILLE58 BD CHARLES LIVON MARSEILLE 13007
ASSISTANCE PUBLIQUE-HOPITAUX DE MARSEILLE80 RUE BROCHIER MARSEILLE F-13005

International Classification(s)

loading....
  • 2013 Application Filing Year
  • G01N Class
  • 9056 Applications Filed
  • 7640 Patents Issued To-Date
  • 84.37 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2013201420152016201720182019202020212022202320240255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Auger, Isabelle Marseille Cedex 09, FR 7 11
Lambert, Nathalie Marseille Cedex 09, FR 3 2
Roudier, Jean Marseille Cedex 09, FR 8 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 1 Citation Count
  • G01N Class
  • 23.45 % this patent is cited more than
  • 10 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges131532435882191024326142012121401 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +020040060080010001200140016001800200022002400260028003000320034003600

Forward Cite Landscape

Load Citation